| Name | Ethyl 2-(4-chloropyrimidin-5-yl)acetate |
|---|---|
| Synonyms | ethyl 2-(4-chloropyrimidin-5-yl)acetate |
| Density | 1.277g/cm3 |
|---|---|
| Boiling Point | 289.286ºC at 760 mmHg |
| Molecular Formula | C8H9ClN2O2 |
| Molecular Weight | 200.62200 |
| Flash Point | 128.756ºC |
| Exact Mass | 200.03500 |
| PSA | 52.08000 |
| LogP | 1.23560 |
| Index of Refraction | 1.522 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~93%
6214-47-7 |
| Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; Location in patent: Page/Page column 134 ; |
|
~%
6214-47-7 |
| Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
|
~%
6214-47-7 |
| Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
|
~%
6214-47-7 |
| Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |